Beck Capital Management’s Pfizer PFE Stock Holding History

Beck Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-12,601	Closed	-$421K	–	116
2016 Q2	$421K	Buy	+12,601	New	+$402K	0.27%	76
2016 Q1	–	Sell	-5,080	Closed	-$156K	–	135
2015 Q4	$156K	Buy	+5,080	New	+$160K	0.09%	123
2014 Q3	–	Sell	-63,111	Closed	-$1.78M	–	163
2014 Q2	$1.78M	Buy	63,111 +25,889	+70%	+$738K	1.18%	22
2014 Q1	$1.13M	Buy	37,222 +134	+0.4%	+$4K	0.86%	38
2013 Q4	$1.06M	Buy	+37,088	New	+$1.08M	0.85%	38

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Beck Capital Management's PFE Position: Q3 2016 in Review

Beck Capital Management sold out of Pfizer (PFE) in Q3 2016, closing a stake of 12,601 shares — an estimated $421K sold.

Beck Capital Management first reported a position in PFE in Q4 2013 and held it in 5 quarters. The position peaked at $1.78M in Q2 2014. 1,964 funds tracked by Wall St. Rank hold PFE as of Q3 2016.

Beck Capital Management reported no remaining Pfizer position as of Q3 2016 after selling out during the quarter.
Beck Capital Management sold 12,601 Pfizer shares in Q3 2016, an estimated $421K.
Beck Capital Management first reported a position in Pfizer in Q4 2013 and held it in 5 quarters.
Beck Capital Management's Pfizer position peaked at $1.78M in Q2 2014.
1,964 funds tracked by Wall St. Rank held Pfizer as of Q3 2016.

Based on Beck Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.